There are significant questions on how the order can be implemented, and if companies can raise prices on already approved drugs, analysts say.

Pfizer (PFE), and Eli Lilly (LLY) traded in the green Monday morning despite declining in pre-market hours after President Donald Trump signed a new executive order that will push drugmakers to sell ...

Eli Lilly (NYSE:LLY ... The latest executive order on drug prices by President Donald Trump has only added to its woes, or has it? The order signed on May 12 aims to align U.S. drug prices ...

The U.S. imports more pharmaceutical products from Ireland than from any other country -- nearly $50 billion last year. It won't be surprising if the Trump administration especially targets those ...

The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...

President Trump, who has vowed to lower drugs prices by as much as 80 per cent ... Huge US companies — think AbbVie, Eli Lilly and Pfizer — derive between 70 and 90 per cent of their sales from it, ...

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

Trump's order seeks to ease regulations to compel more U.S. drug manufacturing. He also plans to assess tariffs on drug ...

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

Eli Lilly's (NYSE: LLY) share price soared during the first Trump administration. That momentum continued with Joe Biden in the White House. However, it's a much different story so far in Trump's ...